Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Diabetes Care|July 14, 2017
Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and <i>HLA-DQ</i> Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 DiabetesFrans K Gorus, Eric V Balti, Anissa Messaaoui, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2018
Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World StudySara Charleer, Chantal Mathieu, Frank Nobels, et al.
Diabetes Research and Clinical Practice|October 26, 2023
Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetesAster K Desouter, Bart Keymeulen, Simke Demeester, et al.
Stem Cells Translational Medicine|August 6, 2019
Cell Mass Increase Associated with Formation of Glucose-Controlling β-Cell Mass in Device-Encapsulated Implants of hiPS-Derived Pancreatic EndodermThomas Robert, Ines De Mesmaeker, Freya O Van Hulle, et al.
Diabetologia|August 27, 2021
Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relativesJulie Vandewalle, Bart J Van der Auwera, Henna Amin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 17, 2021
Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes MellitusAnass El Malahi, Michiel Van Elsen, Sara Charleer, et al.
Heliyon|April 8, 2025
The stage- and subgroup-specific impact of non-HLA polymorphisms on preclinical type 1 diabetes progressionJulie Vandewalle, Aster K Desouter, Bart J Van der Auwera, et al.
Diabetes Care|April 30, 2002
The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestationIlse Weets, Ivo H De Leeuw, Marc V L Du Caju, et al.
Diabetes|April 24, 2010
Beta-cell replication is increased in donor organs from young patients after prolonged life supportPeter In't Veld, Neelke De Munck, Kristien Van Belle, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trialLorenzo Piemonti, Bart Keymeulen, Pieter Gillard, et al.
Pageof 14